![Nxera Team](/_next/image?url=https%3A%2F%2Fsosei-heptares.ams3.cdn.digitaloceanspaces.com%2F_2000xAUTO_crop_center-center_none%2FNxera-Team.jpeg&w=3840&q=75)
Team
Our management team, board and scientific advisory board have vast experience in the global pharma industry and provide a wealth of expertise.
Executive Officers
Board of Directors
![A portrait of Mr. Kuniaki Kaga](/_next/image?url=https%3A%2F%2Fsosei-heptares.ams3.cdn.digitaloceanspaces.com%2F_600xAUTO_crop_center-center_none%2FMr-Kuniaki-Kaga.png&w=3840&q=75)
Mr. Kuniaki Kaga
External Independent Director
Kuniaki has over 40 years’ experience gained at leading chemical and pharmaceutical companies in Japan. From 1975 to 2009, he was at Mitsubishi Chemical Holdings Corporation, where he held several leadership roles including Executive Officer and Head of Healthcare Strategy Office, and Head of Healthcare Planning. He is currently an Adviser to Mitsubishi Chemical Corporation.
From 2009, Kuniaki was at Mitsubishi Tanabe Pharma in Board and senior executive roles, including Representative Director, Senior Managing Executive Officer, General Manager of Research Division and International Business Department. In 2014 he was appointed President and Representative Director of The KAITEKI Institute, Inc. He is also an External Director of SUSMED, Inc.
Kuniaki joined the Board of Directors of Nxera Pharma in June 2018.